Literature DB >> 17001309

Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.

R S Bindra1, P M Glazer.   

Abstract

We and others have shown that the dysregulation of DNA repair pathways can contribute to the phenomenon of hypoxia-induced genetic instability within the tumor microenvironment. Several studies have revealed that the recombinational repair genes, RAD51 and BRCA1, and the DNA mismatch repair genes, MLH1 and MSH2, are decreased in expression in response to hypoxic stress, prompting interest in elucidating the mechanistic basis for these responses. Here we report that the downregulation of RAD51 by hypoxia is specifically mediated by repressive E2F4/p130 complexes that bind to a single E2F site in the proximal promoter of the gene. Intriguingly, this E2F site is conserved in the promoter of the BRCA1 gene, which is also regulated by a similar mechanism in hypoxia. Mechanistically, we have found that hypoxia induces substantial p130 dephosphorylation and nuclear accumulation, leading to the formation of E2F4/p130 complexes and increased occupancy of E2F4 and p130 at the RAD51 and BRCA1 promoters. These findings reveal a coordinated transcriptional program mediated by the formation of repressive E2F4/p130 complexes that represents an integral response to hypoxic stress. In addition, this co-regulation of key factors within the homology-dependent DNA repair pathway provides a further basis for understanding genetic instability in tumors and may guide the design of new therapeutic strategies for cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001309     DOI: 10.1038/sj.onc.1210001

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  76 in total

Review 1.  Tumor hypoxia and genetic alterations in sporadic cancers.

Authors:  Minoru Koi; Clement R Boland
Journal:  J Obstet Gynaecol Res       Date:  2011-01-27       Impact factor: 1.730

Review 2.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

3.  Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2014-03-31       Impact factor: 5.852

4.  PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF.

Authors:  Parker L Sulkowski; Susan E Scanlon; Sebastian Oeck; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2018-05-08       Impact factor: 5.852

Review 5.  E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA.

Authors:  Dragos Plesca; Meredith E Crosby; Damodar Gupta; Alexandru Almasan
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

Review 6.  Pharmacological methods to transcriptionally modulate double-strand break DNA repair.

Authors:  Alanna R Kaplan; Peter M Glazer
Journal:  Int Rev Cell Mol Biol       Date:  2019-12-18       Impact factor: 6.813

7.  E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks.

Authors:  Jie Chen; Feng Zhu; Regina L Weaks; Anup K Biswas; Ruifeng Guo; Yanjie Li; David G Johnson
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

8.  Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance.

Authors:  Devon M Fitzgerald; P J Hastings; Susan M Rosenberg
Journal:  Annu Rev Cancer Biol       Date:  2017-03

9.  BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy.

Authors:  Kristin Tracy; Benjamin C Dibling; Benjamin T Spike; James R Knabb; Paul Schumacker; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2007-06-18       Impact factor: 4.272

10.  MicroRNA regulation of DNA repair gene expression in hypoxic stress.

Authors:  Meredith E Crosby; Ritu Kulshreshtha; Mircea Ivan; Peter M Glazer
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.